| Features: |
| The ketogenic diet is a high-fat, moderate-protein, and very low-carbohydrate diet. The drastic reduction in carbohydrate intake aims to shift the body’s metabolism from relying primarily on glucose (sugar) for energy to using ketone bodies produced from fat metabolism. Many cancer cells predominantly rely on glucose for energy—a phenomenon known as the Warburg effect. By reducing carbohydrate intake, the KD lowers blood glucose levels, which theoretically could "starve" cancer cells of their preferred energy source. -Lowering carbohydrate intake reduces insulin levels, which may indirectly decrease insulin-like growth factor (IGF) signaling—a pathway that can promote tumor growth in some cancers. - MCT oil is rapidly metabolized in the liver to produce ketone bodies, making it a common component of ketogenic diets. |
| Source: |
| Type: |
| The selectivity of cancer products (such as chemotherapeutic agents, targeted therapies, immunotherapies, and novel cancer drugs) refers to their ability to affect cancer cells preferentially over normal, healthy cells. High selectivity is important because it can lead to better patient outcomes by reducing side effects and minimizing damage to normal tissues. Achieving high selectivity in cancer treatment is crucial for improving patient outcomes. It relies on pinpointing molecular differences between cancerous and normal cells, designing drugs or delivery systems that exploit these differences, and overcoming intrinsic challenges like tumor heterogeneity and resistance Factors that affect selectivity: 1. Ability of Cancer cells to preferentially absorb a product/drug -EPR-enhanced permeability and retention of cancer cells -nanoparticle formations/carriers may target cancer cells over normal cells -Liposomal formations. Also negatively/positively charged affects absorbtion 2. Product/drug effect may be different for normal vs cancer cells - hypoxia - transition metal content levels (iron/copper) change probability of fenton reaction. - pH levels - antiOxidant levels and defense levels 3. Bio-availability |
| 1810- | dietKeto, | Oxy, | The Ketogenic Diet and Hyperbaric Oxygen Therapy Prolong Survival in Mice with Systemic Metastatic Cancer |
| - | in-vivo, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:283 Target#:1110 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid